We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$69.2B
1-Year Est. Return
41.24%
This Quarter
Est. Return
+3.88%
1 Year Est. Return
+41.24%
3 Year Est. Return
+116.24%
5 Year Est. Return
+151.83%
10 Year Est. Return
+590.13%
AUM
$56.7B
AUM Growth
+$8.88B
(+19%)
Cap. Flow
+$7.92B
Cap. Flow
% of AUM
13.98%
Top 10 Holdings %
Top 10 Hldgs %
34.05%
Holding
2,107
New
102
Increased
1,467
Reduced
463
Closed
73
Avg Time Held
24
quarters
Top 10 Avg Time Held
22.8
quarters
Top 20 Avg Time Held
20.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$779M |
| 2 |
Apple
AAPL
|
+$539M |
| 3 |
Microsoft
MSFT
|
+$522M |
| 4 |
Meta Platforms (Facebook)
META
|
+$487M |
| 5 |
Tesla
TSLA
|
+$414M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$189M |
| 2 |
C.H. Robinson
CHRW
|
+$55.4M |
| 3 |
Fortinet
FTNT
|
+$55M |
| 4 |
AbbVie
ABBV
|
+$35.7M |
| 5 |
NextEra Energy
NEE
|
+$32.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.38% |
| 2 | Communication Services | 10.74% |
| 3 | Consumer Discretionary | 10.59% |
| 4 | Industrials | 8.58% |
| 5 | Consumer Staples | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1976
Agilon Health
AGL
$1.38B
| $38.7K | ﹤0.01% |
2,251
+140
| +7% | +$2.71K |
2024 Q3
5 quarters
|
|
1977
VTEX
VTEX
$656M
| $38.7K | ﹤0.01% |
+10,285
| New | +$42.2K |
2025 Q4
0 quarters
|
|
1978
Accendra Health
ACH
$32.9M
| $38.6K | ﹤0.01% |
13,781
+886
| +7% | +$3.17K |
2020 Q3
21 quarters
|
|
1979
JELD-WEN Holding
JELD
$134M
| $38.2K | ﹤0.01% |
15,514
+974
| +7% | +$3.2K |
2023 Q2
10 quarters
|
|
1980
Alpha Teknova
TKNO
$475M
| $38K | ﹤0.01% |
+10,002
| New | +$48.7K |
2025 Q4
0 quarters
|
|
1981
New Fortress Energy
NFE
$24.9M
| $36.6K | ﹤0.01% |
642
-131
| -17% | -$9.66K |
2025 Q2
2 quarters
|
|
1982
Heron Therapeutics
HRTX
$77.1M
| $36.5K | ﹤0.01% |
28,075
+1,916
| +7% | +$2.37K |
2020 Q2
22 quarters
|
|
1983
SelectQuote
SLQT
$64.2M
| $36.1K | ﹤0.01% |
25,583
+2,081
| +9% | +$3.48K |
2021 Q1
19 quarters
|
|
1984
Humacyte
HUMA
$113M
| $35.2K | ﹤0.01% |
36,623
+9,551
| +35% | +$13.5K |
2021 Q4
16 quarters
|
|
1985
Coherus Oncology
CHRS
$165M
| $35.1K | ﹤0.01% |
24,718
+6,583
| +36% | +$9.59K |
2015 Q4
40 quarters
|
|
1986
Rezolute
RZLT
$471M
| $34.8K | ﹤0.01% |
14,757
+1,529
| +12% | +$12K |
2025 Q2
2 quarters
|
|
1987
DELISTED
Olaplex Holdings
OLPX
| $34.5K | ﹤0.01% |
25,758
+1,733
| +7% | +$2.06K |
2024 Q3
5 quarters
|
|
1988
Aspen Aerogels
ASPN
$469M
| $34.3K | ﹤0.01% |
12,118
+780
| +7% | +$4.02K |
2024 Q3
5 quarters
|
|
1989
loanDepot
LDI
$190M
| $33.8K | ﹤0.01% |
16,311
+2,140
| +15% | +$5.94K |
2025 Q2
2 quarters
|
|
1990
Unisys
UIS
$162M
| $33.6K | ﹤0.01% |
12,191
+781
| +7% | +$2.44K |
2023 Q4
8 quarters
|
|
1991
Entravision Communication
EVC
$621M
| $33.3K | ﹤0.01% |
11,369
+731
| +7% | +$1.9K |
2024 Q3
5 quarters
|
|
1992
DELISTED
TrueCar
TRUE
| $33K | ﹤0.01% |
14,604
+1,142
| +8% | +$2.45K |
2022 Q4
12 quarters
|
|
1993
Codexis
CDXS
$154M
| $32.9K | ﹤0.01% |
20,214
+2,999
| +17% | +$6.12K |
2024 Q3
5 quarters
|
|
1994
Nano X Imaging
NNOX
$42.3M
| $32.9K | ﹤0.01% |
11,742
+755
| +7% | +$2.71K |
2024 Q3
5 quarters
|
|
1995
Cardiff Oncology
CRDF
$84M
| $31.8K | ﹤0.01% |
11,328
+728
| +7% | +$1.69K |
2024 Q4
4 quarters
|
|
1996
Douglas Elliman
DOUG
$141M
| $31.7K | ﹤0.01% |
13,376
+838
| +7% | +$2.15K |
2025 Q2
2 quarters
|
|
1997
OraSure Technologies
OSUR
$269M
| $31.4K | ﹤0.01% |
12,966
+109
| +0.8% | +$287 |
2024 Q3
5 quarters
|
|
1998
Invivyd
IVVD
$213M
| $30.2K | ﹤0.01% |
+12,240
| New | +$25.5K |
2025 Q4
0 quarters
|
|
1999
Perspective Therapeutics
CATX
$304M
| $29.9K | ﹤0.01% |
10,889
+699
| +7% | +$1.99K |
2024 Q3
5 quarters
|
|
2000
W&T Offshore
WTI
$548M
| $29.6K | ﹤0.01% |
18,139
+1,164
| +7% | +$2.23K |
2020 Q2
22 quarters
|
|
Similar funds
ProShare Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, ProShare Advisors held 2,107 positions worth $56.7B, up 19% from $47.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
ProShare Advisors deployed $7.92B of net new capital in Q4 2025, opening 102 new positions and adding to 1,467 existing holdings. Its largest new stake was CRH: 131,018 shares worth $16.4M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Broadcom, an estimated $189M trimmed.
- ProShare Advisors's largest Q4 2025 buy was CRH: 131,018 shares worth $16.4M.
- ProShare Advisors added most to NVIDIA in Q4 2025, an estimated $779M increase.
- ProShare Advisors's biggest Q4 2025 reduction was Broadcom, cutting an estimated $189M.
- ProShare Advisors fully exited Perrigo in Q4 2025, selling an estimated $27.6M.
- ProShare Advisors's ten largest holdings make up 34% of its $56.7B portfolio in Q4 2025.
- ProShare Advisors opened 102 new positions and closed 73 in Q4 2025.
- ProShare Advisors's portfolio value rose 19% quarter-over-quarter to $56.7B.
Based on ProShare Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.